HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.

Abstract
Arsenic-contaminated well water has been shown to increase the risk of atherosclerosis. Because of involving S-adenosylmethionine, homocysteine may modify the risk by interfering with the biomethylation of ingested arsenic. In this study, we assessed the effect of plasma homocysteine level and urinary monomethylarsonic acid (MMA(V)) on the risk of atherosclerosis associated with arsenic. In total, 163 patients with carotid atherosclerosis and 163 controls were studied. Lifetime cumulative arsenic exposure from well water for study subjects was measured as index of arsenic exposure. Homocysteine level was determined by high-performance liquid chromatography (HPLC). Proportion of MMA(V) (MMA%) was calculated by dividing with total arsenic species in urine, including arsenite, arsenate, MMA(V), and dimethylarsinic acid (DMA(V)). Results of multiple linear regression analysis show a positive correlation of plasma homocysteine levels to the cumulative arsenic exposure after controlling for atherosclerosis status and nutritional factors (P < 0.05). This correlation, however, did not change substantially the effect of arsenic exposure on the risk of atherosclerosis as analyzed in a subsequent logistic regression model. Logistic regression analyses also show that elevated plasma homocysteine levels did not confer an independent risk for developing atherosclerosis in the study population. However, the risk of having atherosclerosis was increased to 5.4-fold (95% CI, 2.0-15.0) for the study subjects with high MMA% (> or =16.5%) and high homocysteine levels (> or =12.7 micromol/l) as compared to those with low MMA% (<9.9%) and low homocysteine levels (<12.7 micromol/l). Elevated homocysteinemia may exacerbate the formation of atherosclerosis related to arsenic exposure in individuals with high levels of MMA% in urine.
AuthorsMeei-Maan Wu, Hung-Yi Chiou, Yu-Mei Hsueh, Chi-Tzong Hong, Che-Long Su, Shu-Feng Chang, Wen-Ling Huang, Hui-Ting Wang, Yuan-Hung Wang, Yi-Chen Hsieh, Chien-Jen Chen
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 216 Issue 1 Pg. 168-75 (Oct 01 2006) ISSN: 0041-008X [Print] United States
PMID16806340 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Arsenicals
  • Cholesterol, LDL
  • Homocysteine
  • Cacodylic Acid
  • monomethylarsonic acid
  • Arsenic
Topics
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Arsenic (blood, urine)
  • Arsenicals (blood, urine)
  • Atherosclerosis (blood, etiology, urine)
  • Cacodylic Acid (urine)
  • Carotid Artery Diseases (blood, etiology, urine)
  • Cholesterol, LDL (blood)
  • Female
  • Homocysteine (blood)
  • Humans
  • Logistic Models
  • Male
  • Multivariate Analysis
  • Odds Ratio
  • Risk Factors
  • Sex Factors
  • Time Factors
  • Water Pollution (adverse effects, analysis)
  • Water Supply (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: